The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
Open accessAbstract
Despite the discovery of 5 alpha-reduction as an enzymatic step in steroid metabolism in 1951, and the discovery that dihydrotestosterone is more potent than testosterone in 1968, the significance of 5 alpha-reduced steroids in human diseases was not appreciated until the discovery of 5 alpha-reductase type 2 deficiency in 1974. Affected males are born with ambiguous external genitalia, despite normal internal genitalia. The prostate is hypoplastic, nonpalpable on rectal examination and approximately 1/10th the size of age-matched normal glands. Benign prostate hyperplasia or prostate cancer does not develop in these patients. At puberty, the external genitalia virilize partially, however, secondary sexual hair remains sparse and male pattern baldness and acne develop rarely. Several compounds have been developed to inhibit the 5 alpha-reductase isozymes and they play an important role in the prevention and treatment of many common diseases. This review describes the basic biochemical properties, functions, tissue distribution, chromosomal location, and clinical significance of the 5 alpha-reductase isozyme family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Comparison of finasteride versus flutamide in the treatment of hirsutism
Falsetti, L., Gambera, A., Legrenzi, L., Iacobello, C., & Bugari, G. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410361 · Cited by 79
RetractedGene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Investigative Ophthalmology and Visual Science
Frey, C. (2010) · Cited by 3,350
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism
Imperato-McGinley, J., Guerrero, L., Gautier, T., & Peterson, R. E. (1974) · Science · doi:10.1126/science.186.4170.1213 · Cited by 1,258
Effect of Dutasteride on the Risk of Prostate Cancer
Andriole, G. L., Bostwick, D. G., Brawley, O. W., Gomella, L. G., Marberger, M., Montorsi, F., Pettaway, C. A., Tammela, T. L., Teloken, C., Tindall, D. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908127 · Cited by 1,152
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
Scher, H. I., Beer, T. M., Higano, C. S., Anand, A., Taplin, M.-E., Efstathiou, E., Rathkopf, D., Shelkey, J., Yu, E. Y., Alumkal, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60172-9 · Cited by 1,063
Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903
Finasteride in the treatment of men with androgenetic alopecia
Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70007-6 · Cited by 772
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., & Russell, D. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116665 · Cited by 727
The Androgen Axis in Recurrent Prostate Cancer
Mohler, J. L., Gregory, C. W., Ford, O. H., Kim, D., Weaver, C. M., Petrusz, P., Wilson, E. M., & French, F. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1146-03 · Cited by 675
Self-citationSelection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
Taplin, M., Bubley, G. J., Ko, Y., Small, E. J., Upton, M. P., Rajeshkumar, B. R., & Balk, S. P. (1999) · PubMed · Cited by 596
Testosterone Formation and Metabolism During Male Sexual Differentiation in the Human Embryo
SIITERI, P. K., & WILSON, J. D. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-1-113 · Cited by 593
(2001) · PubMed · Cited by 500
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0525 · Cited by 488
Self-citationClark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030330 · Cited by 467
Regulation of androgen receptor activity by tyrosine phosphorylation.
Guo, Z., Dai, B., Jiang, T., Xu, K., Xie, Y., Kim, O., Nesheiwat, I., Kong, X., Melamed, J., Handratta, V. D., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.021 · Cited by 364
McConnell, J. D. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.505 · Cited by 325
Cantagrel, V., Lefeber, D. J., Ng, B. G., Guan, Z., Silhavy, J. L., Bielas, S. L., Lehle, L., Hombauer, H., Adamowicz, M., Swiezewska, E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.001 · Cited by 309
Androgens and male physiology the syndrome of 5α-reductase-2 deficiency
Imperato-McGinley, J., & Zhu, Y.-S. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00368-4 · Cited by 306
Olsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., Wilson, T., & Rittmaster, R. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.007 · Cited by 303
Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer
Uemura, M., Tamura, K., Chung, S., Honma, S., Okuyama, A., Nakamura, Y., & Nakagawa, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00656.x · Cited by 263
An overview on 5α-reductase inhibitors
Aggarwal, S., Thareja, S., Verma, A., Bhardwaj, T. R., & Kumar, M. (2010) · Steroids · doi:10.1016/j.steroids.2009.10.005 · Cited by 223
Nickel, J. C., Gilling, P., Tammela, T. L., Morrill, B., Wilson, T. H., & Rittmaster, R. S. (2011) · BJU International · doi:10.1111/j.1464-410x.2011.10195.x · Cited by 218
SAARTOK, T., DAHLBERG, E., & GUSTAFSSON, J.-Å. (1984) · Endocrinology · doi:10.1210/endo-114-6-2100 · Cited by 215
Identification of Two Mammalian Reductases Involved in the Two-carbon Fatty Acyl Elongation Cascade
Moon, Y.-A., & Horton, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211684200 · Cited by 215
DRAKE, L., HORDINSKY, M., FIEDLER, V, SWINEHART, J., UNGER, W., COTTERILL, P., THIBOUTOT, D., LOWE, N., JACOBSON, C., & WHITING, D. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70295-1 · Cited by 210
Nomenclature of steroids (Recommendations 1989)
Moss, G. P. (1989) · Pure and Applied Chemistry · doi:10.1351/pac198961101783 · Cited by 206
Moghetti, P., Tosi, F., Tosti, A., Negri, C., Misciali, C., Perrone, F., Caputo, M., Muggeo, M., & Castello, R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6245 · Cited by 201
Thomas, L. N., Lazier, C. B., Gupta, R., Norman, R. W., Troyer, D. A., O'Brien, S. P., & Rittmaster, R. S. (2005) · The Prostate · doi:10.1002/pros.20188 · Cited by 179
The Effect of Castration on Benign Hypertrophy of the Prostate in Man
Huggins, C., & Stevens, R. A. (1940) · Journal of Urology · doi:10.1016/s0022-5347(17)71453-x · Cited by 178
Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer
Titus, M. A., Gregory, C. W., Ford, O. H., Schell, M. J., Maygarden, S. J., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0738 · Cited by 176
Self-citationDihydrotestosterone Formation in Fetal Tissues of the Rabbit and Rat
WILSON, J. D., & LASNITZKI, I. (1971) · Endocrinology · doi:10.1210/endo-89-3-659 · Cited by 173
Recent Studies on the Mechanism of Action of Testosterone
Deykin, D., Balko, C., & Wilson, J. D. (1972) · New England Journal of Medicine · doi:10.1056/nejm197212212872508 · Cited by 171
Agoulnik, I. U., Vaid, A., Nakka, M., Alvarado, M., Bingman, W. E., Erdem, H., Frolov, A., Smith, C. L., Ayala, G. E., Ittmann, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1023 · Cited by 168
Rathnayake, D., & Sinclair, R. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003752730 · Cited by 165
ANDRIOLE, G. L., HUMPHREY, P., RAY, P., GLEAVE, M. E., TRACHTENBERG, J., THOMAS, L. N., LAZIER, C. B., & RITTMASTER, R. S. (2004) · Journal of Urology · doi:10.1097/01.ju.0000136430.37245.b9 · Cited by 164
Mohler, J. L., Titus, M. A., Bai, S., Kennerley, B. J., Lih, F. B., Tomer, K. B., & Wilson, E. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1343 · Cited by 162
Self-citationAcne: hormonal concepts and therapy
Thiboutot, D. (2004) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.03.010 · Cited by 155
Eun, H. C., Kwon, O., Yeon, J. H., Shin, H., Kim, B. Y., Ro, B. I., Cho, H. K., Sim, W., Lew, B., Lee, W., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.09.018 · Cited by 154
THE ENZYMATIC REDUCTION OF Δ4-3-KETOSTEROIDS
Tomkins, G. M., & Michael, P. J. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64906-3 · Cited by 153
Androgen Receptor Gene Amplification and Protein Expression in Recurrent Prostate Cancer
Ford, O. H., Gregory, C. W., Kim, D., Smitherman, A. B., & Mohler, J. L. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000091873.09677.f4 · Cited by 150
Self-citationKONDO, K., KAI, M., SETOGUCHI, Y., EGGERTSEN, G., SJÖBLOM, P., SETOGUCHI, T., OKUDA, K., & BJÖRKHEM, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19947.x · Cited by 139
Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer
Thomas, L. N., Douglas, R. C., Lazier, C. B., Too, C. K. L., Rittmaster, R. S., & Tindall, D. J. (2007) · European Urology · doi:10.1016/j.eururo.2007.10.052 · Cited by 131
The 5α-Recluctase System and Its Inhibitors
Chen, W., Zouboulis, C. C., & Orfanos, C. E. (2009) · Dermatology · doi:10.1159/000246242 · Cited by 127
Iehlé, C., Radvanyi, F., de Medina, S. G. D., Ouafik, L., Gérard, H., Chopin, D. K., Raynaud, J., & Martin, P. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00030-8 · Cited by 123
The Effect of Castration on Benign Hypertrophy of the Prostate in Man
Huggins, C., & Stevens, R. A. (2016) · The Journal of Urology · doi:10.1016/j.juro.2016.10.075 · Cited by 122
Treatment with finasteride following radical prostatectomy for prostate cancer
Andriole, G. L., Lieber, M., Smith, J. A., Soloway, M. S., Schroeder, F. W., Kadmon, D., deKernion, J. B., Rajfer, J., Boake, R., Crawford, D., et al. (1995) · Urology · doi:10.1016/s0090-4295(99)80021-1 · Cited by 116
Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
Bayne, Flanagan, Einstein, Ayala, Chang, Azzolina, Whiting, Mumford, Thiboutot, Singer, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03042.x · Cited by 114
Godoy, A., Kawinski, E., Li, Y., Oka, D., Alexiev, B. A., Azzouni, F. S., Titus, M. A., & Mohler, J. L. (2010) · The Prostate · doi:10.1002/pros.21318 · Cited by 113
Self-citationDermatologic Manifestations of Polycystic Ovary Syndrome
Lee, A. T., & Zane, L. T. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708040-00003 · Cited by 109
Effective treatment of female androgenic alopecia with dutasteride.
Olszewska, M., & Rudnicka, L. (2005) · PubMed · Cited by 108
Yamana, K., Labrie, F., & Luu-The, V. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.035 · Cited by 107
Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinomas
Bonkhoff, H., Stein, U., Aumüller, G., & REMBERGER, K. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199610)29:4<261::aid-pros7>3.0.co;2-e · Cited by 106
SEPARATION OF Δ4-5α- AND Δ4-5β-HYDROGENASES FROM RAT LIVER HOMOGENATES
Forchielli, E., & Dorfman, R. I. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)65153-1 · Cited by 102
Moore, R. J., Gazak, J. M., Quebbeman, J. F., & Wilson, J. D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109536 · Cited by 99
Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin
Eicheler, W., DREHER, M., Hoffmann, R., Happle, R., & Aumüller, G. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb02663.x · Cited by 97
Evolution of steroid-5α-reductases and comparison of their function with 5β-reductase
Langlois, V. S., Zhang, D., Cooke, G. M., & Trudeau, V. L. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.08.004 · Cited by 93
Stimulation of Mammalian Erythropoiesis by 5β-H Steroid Metabolites
Gordon, A. S., Zanjani, E. D., Levere, R. D., & Kappas, A. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.65.4.919 · Cited by 91
Taplin, M., Regan, M. M., Ko, Y., Bubley, G. J., Duggan, S., Werner, L. L., Beer, T. M., Ryan, C. W., Mathew, P. F., Tu, S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1722 · Cited by 86
The Effect of a 5α;-Reductase Inhibitor on Androgen Mediated Growth of the Dog Prostate*
Wenderoth, U. K., George, F. W., & Wilson, J. D. (1983) · Endocrinology · doi:10.1210/endo-113-2-569 · Cited by 82
Span, P. N., Völler, M., SMALS, A. G. H., Sweep, F. C. G. J., Schalken, J. A., Feneley, M. R., & Kirby, R. S. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62141-4 · Cited by 82
Gleave, M. E., Qian, J., Andreou, C., Pommerville, P. J., Chin, J. L., Casey, R. W., Steinhoff, G., Fleshner, N. E., Bostwick, D. G., Thomas, L. N., et al. (2006) · The Prostate · doi:10.1002/pros.20499 · Cited by 82
Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes
Ntais, C., Polycarpou, A., & Tsatsoulis, A. A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490469 · Cited by 81
Dermatology of androgen-related disorders
Essah, P. A., Wickham, E. P., Nunley, J. R., & Nestler, J. E. (2006) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2006.04.004 · Cited by 80
The clinical evaluation of hirsutism
Somani, N., Harrison, S., & Bergfeld, W. F. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00219.x · Cited by 77
Carmina, E., & Løbo, R. A. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01594.x · Cited by 74
SRD5A3: a surprising role in glycosylation
Stiles, A. R., & Russell, D. W. (2010) · Cell · doi:10.1016/j.cell.2010.07.003 · Cited by 66
Aumüller, G., Eicheler, W., Renneberg, H., Adermann, K., Vilja, P. J., & Forssmann, W. (1996) · Cells Tissues Organs · doi:10.1159/000147852 · Cited by 65
Falsetti, L., Gambera, A., Andrico, S., & Sartori, E. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.4.275.284 · Cited by 65
Selective non-steroidal inhibitors of 5α-reductase type 1
Occhiato, E. G., Guarna, A., Danza, G., & Serio, M. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.10.004 · Cited by 57
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
Shah, S. K., Trump, D. L., Sartor, O. A., Tan, W., Wilding, G. E., & Mohler, J. L. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.10.014 · Cited by 54
Self-citationClinical application of 5α-reductase inhibitors
Cilotti, A., Danza, G., & Serio, M. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343844 · Cited by 54
EFFECTS OF INCUBATING DESOXYCORTICOSTERONE WITH VARIOUS RAT TISSUES
Schneider, J. J., & Horstmann, P. M. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50983-2 · Cited by 49
A systemic type i 5 α-reductase inhibitor is ineffective in the treatment of acne vulgaris
Leyden, J., Bergfeld, W., Drake, L., Dunlap, F., Goldman, M. P., Gottlieb, A. B., Heffernan, M. P., Hickman, J. G., Hordinsky, M., Jarrett, M., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.07.021 · Cited by 48
Tian, G., Stuart, J. D., Moss, M. L., Domanico, P. L., Bramson, H. N., Patel, I. R., Kadwell, S. H., Overton, L. K., & Kost, T. A. (1994) · Biochemistry · doi:10.1021/bi00174a041 · Cited by 47
Habib, F. K., Ross, M., Bayne, C. W., Grigor, K. M., Buck, A. C., Bollina, P. R., & Chapman, K. E. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560509 · Cited by 46
Schwartz, J. I., Tanaka, W. K., Wang, D. Z., Ebel, D. L., Geissler, L. A., Dallob, A. L., Hafkin, B., & Gertz, B. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3912 · Cited by 40
Antinatriuretic and Kaliuretic Activities of the Reduced Derivatives of Aldosterone*
Kenyon, C. J., Brem, A. S., McDermott, M. J., DECONTI, G. A., Latif, S., & Morris, D. J. (1983) · Endocrinology · doi:10.1210/endo-112-5-1852 · Cited by 37
Söderström, T. G., Bjelfman, C., Brekkan, E., Ask, B., Egevad, L., Norlén, B. J., & Rane, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7224 · Cited by 37
Graupp, M., Wehr, E., Schweighofer, N., Pieber, T. R., & Obermayer-Pietsch, B. M. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.026 · Cited by 36
Tay, M. H., Kaufman, D. S., Regan, M. M., Leibowitz, S. B., George, D. J., Febbo, P. G., Manola, J. B., Smith, M. R., Kaplan, I. D., Kantoff, P. W., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh221 · Cited by 34
Shirakawa, T., Okada, H., Acharya, B., Zhang, Z., Hinata, N., Wada, Y., Uji, T., Kamidono, S., & Gotoh, A. (2003) · The Prostate · doi:10.1002/pros.10313 · Cited by 31
Barqawi, A. B., Moul, J. W., Ziada, A. M., Handel, L. N., & Crawford, E. D. (2003) · Urology · doi:10.1016/s0090-4295(03)00667-8 · Cited by 28
Milewich, L., Gómez-Sánchez, C. E., CROWLEY, G., Porter, J. C., Madden, J. D., & MacDonald, P. C. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-4-617 · Cited by 28
5α-Reductase Isozymes in the Prostate.
Zhu, Y., & Sun, G. (2005) · PubMed · Cited by 26
Expression of the Type 1 and Type 2 Steroid 5α-Reductases in Human Fetal Tissues
Ellsworth, K. P., & Harris, G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2530 · Cited by 23
Sartor, O., Nakabayashi, M., Taplin, M., Ross, R. W., Kantoff, P. W., Balk, S. P., & Oh, W. K. (2009) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2009.n.030 · Cited by 20
5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro.
Weinstein, B. I., Kandalaft, N., Ritch, R. H., Camras, C. B., Morris, D. J., Latif, S., Vecsei, P., Vittek, J., Gordon, G. G., & Southren, A. L. (1991) · PubMed · Cited by 14
Lunacek, A., Schwentner, C., Oswald, J., Fritsch, H., Sergi, C. M., Thomas, L. N., Rittmaster, R. S., Klocker, H., Neuwirt, H., Bartsch, G., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.089 · Cited by 11
Perrotti, M., Jain, R., Abriel, L. M., Baroni, T. E., Corbett, A. B., & Tenenbaum, S. A. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.01.004 · Cited by 9
Twin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadism
Campo, S., Campo, V., & Lanzone, A. (2002) · Gynecological Endocrinology · doi:10.1080/713602993 · Cited by 8
Cited by
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Anticancer steroids: linking natural and semi-synthetic compounds
Salvador, J. A. R., Carvalho, J. F. S., Neves, M. A. C., Silvestre, S. M., Leitão, A. J., Silva, M. M. C., & Sá e Melo, M. L. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20082a · Cited by 276
5α-Reductases in human physiology: an unfolding story
Traish, A. M. (2012) · Endocrine Practice · doi:10.4158/ep12108.ra · Cited by 57
Lephart, E. D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061193 · Cited by 50
So similar and so different: Circulating androgens and androgen origin in bulimic women
Naessén, S., Söderqvist, G., & Carlström, K. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.08.013 · Cited by 8
Metadata
- Authors
- Azzouni, F., Godoy, A., Li, Y., & Mohler, J.
- Venue
- Advances in Urology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-18
- ISSN
- 1687-6369 (ISSN-L)
- 1687-6377
- OpenAlex
- W2033562626
- Cited by
- 333
- References
- 96
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.